Suppr超能文献

草药膳食补充剂导致的肝毒性:过去、现在和未来。

Hepatotoxicity due to herbal dietary supplements: Past, present and the future.

机构信息

National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS, USA; Center for Dietary Supplement Research, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.

Department of Environmental Health Sciences, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA; Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA; Center for Dietary Supplement Research, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.

出版信息

Food Chem Toxicol. 2022 Nov;169:113445. doi: 10.1016/j.fct.2022.113445. Epub 2022 Sep 29.

Abstract

Dietary supplements (DS) constitute a widely used group of products comprising vitamin, mineral, and botanical extract formulations. DS of botanical or herbal origins (HDS) comprise nearly 30% of all DS and are presented on the market either as single plant extracts or multi-extract-containing products. Despite generally safe toxicological profiles of most products currently present on the market, rising cases of liver injury caused by HDS - mostly by multi-ingredient and adulterated products - are of particular concern. Here we discuss the most prominent historical cases of HDS-induced hepatotoxicty - from Ephedra to Hydroxycut and OxyELITE Pro-NF, as well as products with suspected hepatotoxicity that are either currently on or are entering the market. We further provide discussion on overcoming the existing challenges with HDS-linked hepatotoxicity by introduction of advanced in silico, in vitro, in vivo, and microphysiological system approaches to address the matter of safety of those products before they reach the market.

摘要

膳食补充剂(DS)是一组广泛使用的产品,包括维生素、矿物质和植物提取物配方。植物或草药来源的 DS(HDS)占所有 DS 的近 30%,并以单一植物提取物或含有多种提取物的产品形式在市场上销售。尽管目前市场上大多数产品的毒理学特性通常是安全的,但 HDS 引起的肝损伤病例不断增加,尤其是由多种成分和掺假产品引起的肝损伤,这尤其令人担忧。在这里,我们讨论了 HDS 引起的肝毒性的一些最突出的历史案例——从麻黄到 Hydroxycut 和 OxyELITE Pro-NF,以及那些目前在市场上或即将进入市场的具有疑似肝毒性的产品。我们进一步讨论了通过引入先进的计算、体外、体内和微生理系统方法来克服与 HDS 相关的肝毒性的现有挑战,以解决这些产品在进入市场之前的安全性问题。

相似文献

1
Hepatotoxicity due to herbal dietary supplements: Past, present and the future.
Food Chem Toxicol. 2022 Nov;169:113445. doi: 10.1016/j.fct.2022.113445. Epub 2022 Sep 29.
2
Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics.
Int J Mol Sci. 2016 Apr 9;17(4):537. doi: 10.3390/ijms17040537.
3
Botanicals and Hepatotoxicity.
Clin Pharmacol Ther. 2018 Sep;104(3):458-469. doi: 10.1002/cpt.1097. Epub 2018 Jun 19.
4
Drug-induced Liver Injury Secondary to Herbal and Dietary Supplements.
Clin Liver Dis. 2020 Feb;24(1):141-155. doi: 10.1016/j.cld.2019.09.009. Epub 2019 Oct 31.
6
Hepatotoxicity of herbal and dietary supplements: an update.
Arch Toxicol. 2015 Jun;89(6):851-65. doi: 10.1007/s00204-015-1471-3. Epub 2015 Feb 14.
7
Estimated Exposure to 6 Potentially Hepatotoxic Botanicals in US Adults.
JAMA Netw Open. 2024 Aug 1;7(8):e2425822. doi: 10.1001/jamanetworkopen.2024.25822.
8
Herbal and Dietary Supplements-Induced Liver Injury in Latin America: Experience From the LATINDILI Network.
Clin Gastroenterol Hepatol. 2022 Mar;20(3):e548-e563. doi: 10.1016/j.cgh.2021.01.011. Epub 2021 Jan 9.
9
Herbal and dietary supplement hepatotoxicity.
Semin Liver Dis. 2009 Nov;29(4):373-82. doi: 10.1055/s-0029-1240006. Epub 2009 Oct 13.
10
Workshop overview: Hepatotoxicity assessment for botanical dietary supplements.
Toxicol Sci. 2004 May;79(1):4-9. doi: 10.1093/toxsci/kfh075. Epub 2004 Feb 19.

引用本文的文献

1
Botanical-induced toxicity: Liver injury and botanical-drug interactions. A report on a society of Toxicology Annual Meeting symposium.
Regul Toxicol Pharmacol. 2024 Nov;153:105708. doi: 10.1016/j.yrtph.2024.105708. Epub 2024 Sep 19.
3
Inter-strain variability in responses to a single administration of the cannabidiol-rich cannabis extract in mice.
Food Chem Toxicol. 2024 Oct;192:114909. doi: 10.1016/j.fct.2024.114909. Epub 2024 Aug 9.
4
Mercury Levels in Selected Medicines and Dietary Supplements in Poland.
Biol Trace Elem Res. 2025 Mar;203(3):1685-1700. doi: 10.1007/s12011-024-04269-3. Epub 2024 Jun 27.
5
A comprehensive update in herbal and dietary supplement-induced liver injury.
Clin Liver Dis (Hoboken). 2024 Jun 21;23(1):e0185. doi: 10.1097/CLD.0000000000000185. eCollection 2024 Jan-Jun.
6
Hepatotoxicity of usnic acid and underlying mechanisms.
J Environ Sci Health C Toxicol Carcinog. 2025;43(1):1-22. doi: 10.1080/26896583.2024.2366737. Epub 2024 Jun 21.
7
Kratom safety and toxicology in the public health context: research needs to better inform regulation.
Front Pharmacol. 2024 Jun 3;15:1403140. doi: 10.3389/fphar.2024.1403140. eCollection 2024.
9
Cortical ribbon sign on neuroimaging in a patient with hepatic encephalopathy secondary to herbal medicine usage.
Einstein (Sao Paulo). 2023 Nov 13;21:eAI0538. doi: 10.31744/einstein_journal/2023AI0538. eCollection 2023.
10
Unexpected Drug-Induced Liver Injury Associated With MenoFit: A Synbiotic Menopause Supplement.
ACG Case Rep J. 2023 Sep 23;10(9):e01153. doi: 10.14309/crj.0000000000001153. eCollection 2023 Sep.

本文引用的文献

1
Analysis of COVID-19 Pandemic on Supplement Usage and Its Combination with Self-Medication within the State of Arkansas.
J Diet Suppl. 2023;20(2):171-198. doi: 10.1080/19390211.2022.2128500. Epub 2022 Sep 30.
4
Liver organ-on-chip models for toxicity studies and risk assessment.
Lab Chip. 2022 Jun 28;22(13):2423-2450. doi: 10.1039/d2lc00307d.
6
Global Trade Pattern of Traditional Chinese Medicines and China's Trade Position.
Front Public Health. 2022 Apr 28;10:865887. doi: 10.3389/fpubh.2022.865887. eCollection 2022.
7
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review.
J Anal Toxicol. 2022 Jul 14;46(6):e116-e185. doi: 10.1093/jat/bkac023.
8
Analytical Challenges and Metrological Approaches to Ensuring Dietary Supplement Quality: International Perspectives.
Front Pharmacol. 2022 Jan 11;12:714434. doi: 10.3389/fphar.2021.714434. eCollection 2021.
9
Probable Drug-Induced Liver Injury Caused by : A Case Report.
J Clin Exp Hepatol. 2022 Jan-Feb;12(1):232-234. doi: 10.1016/j.jceh.2021.10.002. Epub 2021 Oct 27.
10
Liver Injury Following Tinospora Cordifolia Consumption: Drug-Induced AIH, or AIH?
J Clin Exp Hepatol. 2022 Jan-Feb;12(1):6-9. doi: 10.1016/j.jceh.2021.11.014. Epub 2021 Nov 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验